Shanghai, China

Deyue Yan

USPTO Granted Patents = 5 

Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 2008-2023

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Deyue Yan: Innovator in Antitumor Drug Development

Introduction

Deyue Yan is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative antitumor drugs. With a total of 5 patents to his name, Yan's work is characterized by a focus on enhancing the efficacy of cancer therapies.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Ketone carbonyl-containing hydrophobic antitumor drug and conjugate thereof as well as nano preparation containing conjugate, preparation method therefor, and application thereof." This patent describes a novel amphipathic pH-responsive conjugate created through a dehydration condensation reaction between a hydrazide-terminated polyethylene glycol and/or lactose hydrazide and a ketone carbonyl-introduced hydrophobic antitumor drug. The resulting drug demonstrates higher antitumor activity compared to existing treatments like docetaxel. Another significant patent is focused on "Amphiphilic drug-drug conjugates for cancer therapy, compositions and methods of preparation and uses thereof," which provides new therapeutic options for cancer treatment.

Career Highlights

Deyue Yan has held positions at notable institutions, including Shanghai Jiaotong University and Gore Enterprise Holdings, Inc. His work in these organizations has allowed him to advance his research and contribute to the development of innovative drug therapies.

Collaborations

Throughout his career, Yan has collaborated with esteemed colleagues such as Xinyuan Zhu and Wei Huang. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic solutions.

Conclusion

Deyue Yan's contributions to the field of antitumor drug development highlight his innovative spirit and dedication to improving cancer therapies. His patents reflect a commitment to advancing medical science and providing effective treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…